Open original FDA record ↗Recall record
- FDA identifier
- Z-1094-2015
- Company in FDA record
- Synthes, Inc.
- FDA classification date
- Feb 11, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Revision A of the Hemostatic Bone Putty Brochure (J10847A) was sent to sales consultants instead of Revision B (J10847B), which corrected an error in the indication statement.
Source facts
- Action
- On/about 12/22/2011, emails containing Revision B brochure, as well as instructions to delete/destroy Revision A, were sent to 38 affected individuals (sales consultants). On/about 1/04/2012, follow up phone calls were made to each member of the sales force who had received Rev. A (110847 A) to confirm that they had replaced the Rev. A with the Rev. B (110847 B). In addition, the members of the sales force were asked whether or not the Rev. A had been disseminated to any HCP's. During the follow up conversation, one member of the sales force stated that he had provided the previous version to a surgeon. On 01/06/2012, the sales consultant spoke to the surgeon in person and the surgeon confirmed that he had disposed of the Rev. A.
- Initiated
- 2012-01-06
- Root cause
- Labeling mix-ups
- Terminated
- 2015-03-30
- Distribution
- Distributed in the state of WI
- Recall number
- Z-1094-2015
- Recall status
- Terminated
- CDRH record ID
- 132283
- FDA classified
- 2015-02-11
- Recall event number
- 70055